| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
9e-08 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-06 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
6e-06 |
| mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-06 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-05 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |
| mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |